Clinical laboratory evaluation of rubella virus vaccine given to postpartum women without pregnancy preventive.
D000293:Adolescent; D000328:Adult; D000917:Antibody Formation; D001168:Arthritis / Q000209:etiology; D003364:Costa Rica; D005260:Female; D005334:Fever / Q000209:etiology; D005500:Follow-Up Studies; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007592:Joint Diseases / Q000209:etiology; D008206:Lymphatic Diseases / Q000209:etiology; D008598:Menstruation; D008875:Middle Aged; D049590:Postpartum Period; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D012409:Rubella / Q000276:immunology / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000008:administration & dosage / Q000009:adverse effects; D012412:Rubella virus / Q000276:immunology
D012411:Rubella Vaccine